Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort.

MLA

Gentileschi, Stefano, et al. “Impact of Age and Cardiovascular Risk Factors on the Incidence of Adverse Events in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors: Data from a Real-Life Multicentric Cohort.” Clinical and Experimental Medicine, vol. 24, no. 1, Mar. 2024, p. 62. EBSCOhost, https://doi.org/10.1007/s10238-024-01325-z.

APA

Gentileschi, S., Gaggiano, C., Damiani, A., Coccia, C., Bernardini, P., Cazzato, M., D’Alessandro, F., Vallifuoco, G., Terribili, R., Bardelli, M., Baldi, C., Cantarini, L., Mosca, M., Frediani, B., & Guiducci, S. (2024). Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort. Clinical and Experimental Medicine, 24(1), 62. https://doi.org/10.1007/s10238-024-01325-z

Chicago

Gentileschi, Stefano, Carla Gaggiano, Arianna Damiani, Carmela Coccia, Pamela Bernardini, Massimiliano Cazzato, Francesco D’Alessandro, et al. 2024. “Impact of Age and Cardiovascular Risk Factors on the Incidence of Adverse Events in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors: Data from a Real-Life Multicentric Cohort.” Clinical and Experimental Medicine 24 (1): 62. doi:10.1007/s10238-024-01325-z.